Syndax drops after axatilimab misses MAXPIRe IPF endpoint, while cGVHD program stays on track
Market Chameleon (Tue, 13-Oct 10:59 AM)
Syndax halts axatilimab IPF plans after MAXPIRe misses FVC decline endpoint
Market Chameleon (Tue, 13-Oct 7:33 AM)
